Original Query: ALL
Previous Study | Return to List | Next Study

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma (PMR-MM-002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01241682
Recruitment Status : Completed
First Posted : November 16, 2010
Last Update Posted : February 27, 2014
Information provided by (Responsible Party):
joost hegmans, Erasmus Medical Center